CGI Inc., the Montreal-based IT and business consulting services firm, is a stock with ample analyst coverage, but its average price target does not currently sit far enough above the market to serve as a meaningful headline objective. According to S&P Global data, the average analyst price target is about $83.50, only roughly 1% above the latest trading level — a target that has effectively already been priced in. Individual targets are widely dispersed, from the high-$60s to just above $100, but the cluster of most recent revisions (UBS at $85, Stifel Nicolaus at $86, TD Cowen at $84, RBC Capital at $72, and Desjardins at $82) sits at or near the market.
Because the analyst consensus fails to clear even a modest 10% cushion, this article uses a fallback objective drawn from public technical discussion: a return to the stock's 52-week high near $95.20, rounded to $95. That level is a widely watched prior-high and resistance zone, and it implies roughly 15% upside from the current price. It is a milestone-based target, not a published analyst consensus.
CGI shares trade near $82.50, roughly in the middle of a 52-week range spanning $59.63 to $95.20. Reaching $95 would require a gain of about 15%, which qualifies as a substantial move. The stock has already recovered sharply from its low, and its low beta (near 0.2 on a five-year basis) means it historically moves less than the broader market — a factor that could make a 15% advance more deliberate than sudden.
The path would most plausibly run through reaccelerating organic revenue growth, improving bookings, and margin expansion. CGI's P/E (price-to-earnings ratio) of roughly 14 on trailing earnings is undemanding relative to many technology peers, so valuation re-rating alongside better growth is a credible, if unproven, route toward the prior high. Fiscal 2026 revenue is estimated near C$16.6 billion, and the company reports fourth-quarter and full-year results in November 2026, a key catalyst.
CGI's balance sheet and cash generation support a constructive case. The company has a long record of profitability, a modest dividend yield, and an active share-repurchase program that has helped support earnings per share (EPS). A low valuation leaves room for multiple expansion if organic growth reaccelerates, and management has pointed to areas such as cloud modernization, digital transformation, and artificial-intelligence-related consulting as longer-term demand drivers.
Any meaningful recovery in discretionary enterprise technology spending, stabilization in European and government end-markets, or a pickup in large deal signings would likely be read positively. Analyst revisions would need to turn higher — so far in 2026 the direction of target changes has been mostly downward — for the market to reconsider the prior high.
The principal obstacle is the same concern that drove many target cuts: softer organic growth and margin pressure in a subdued consulting environment. Several firms, including RBC Capital and Scotiabank, have set targets below the current price, and one analyst at Bernstein has maintained a Sell rating. Guidance that underwhelms, weaker bookings, or continued weakness in key regions would keep the stock range-bound well short of $95.
Valuation compression is also a live risk: if growth remains sluggish, the market may be reluctant to pay a higher multiple regardless of how inexpensive the shares already look. Macroeconomic softness, higher-for-longer interest rates, and reduced client budgets for discretionary projects would compound these pressures.
The $95 area is the defining resistance, corresponding to the 52-week high of $95.20 and a round-number psychological level. On the downside, the stock has shown support near the mid-$70s, with the 52-week low of $59.63 marking the lower bound of the longer-term range. A decisive move through the low-$80s toward the high-$80s would need to hold before the prior high becomes realistic. The stock's low volatility and modest beta suggest a slow, range-bound grind rather than explosive breakouts.
Analyst price targets typically reflect a roughly 12-month research horizon, though firms apply their own timeframes and some reports are updated more frequently than others. The most important near-term events are CGI's fiscal fourth-quarter and full-year 2026 results in November 2026, followed by guidance for fiscal 2027, commentary on bookings and organic growth, and any subsequent analyst target revisions. Economic data on enterprise technology budgets and interest-rate expectations are also relevant to the consulting cycle.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals as market conditions, technical behavior, and AI-driven analysis shift. The tool is designed to help traders discover opportunities, track existing positions, and identify changing trends more efficiently than manual review allows. For investors following a name like CGI through earnings season and range-bound price action, automated signal monitoring can offer a useful second perspective alongside fundamental research.
The $95 target for CGI is a technical milestone tied to the stock's 52-week high, implying a substantial 15% advance from the current price near $82.50. It is supported by an inexpensive valuation, durable cash generation, and long-term technology-demand themes, but it is opposed by soft organic growth, cautious guidance, and a 2026 pattern of downward analyst revisions. The analyst community itself is divided — the average target sits essentially at the market, while individual targets stretch from the high-$60s to above $100. Whether the prior high is revisited will depend on a genuine reacceleration in growth and a turn in analyst sentiment, beginning with the upcoming earnings report and fiscal 2027 outlook.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, GIB has been closely correlated with CTSH. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if GIB jumps, then CTSH could also see price increases.
| Ticker / NAME | Correlation To GIB | 1D Price Change % | ||
|---|---|---|---|---|
| GIB | 100% | -0.07% | ||
| CTSH - GIB | 74% Closely correlated | +2.20% | ||
| ACN - GIB | 71% Closely correlated | +1.63% | ||
| EXLS - GIB | 65% Loosely correlated | +2.24% | ||
| GLOB - GIB | 64% Loosely correlated | +2.95% | ||
| G - GIB | 62% Loosely correlated | +1.22% | ||
More | ||||
| Ticker / NAME | Correlation To GIB | 1D Price Change % |
|---|---|---|
| GIB | 100% | -0.07% |
| GIB (3 stocks) | 79% Closely correlated | -1.51% |
| Technology Services (396 stocks) | 12% Poorly correlated | +1.58% |